The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.

CTD² Data Portal

Last Updated: October 26, 2020

Banner for CTD squared program. Links to CTD squared program page The CTD² Network aims to understand the tumor heterogeneity and drug resistance for the development of efficient strategies to identify optimal combinations of small-molecules or immunotherapy with small molecules. The CTD² Data Portal provides access to raw/analyzed primary data generated from different types of approaches e.g. chemical genetics (small-molecules, natural products); genome-wide gain-of-function (cDNA expression libraries, CRISPRa); genome-wide loss-of-function (siRNA, shRNA, CRISPR/Cas9, CRISPRi); protein-protein interactions; and in vivo gain and loss-of function studies.

There are currently {{row_count}} datasets and can be sorted by Center or the assay type.

Users must use data with discretion and acknowledge the CTD² Network.

Centers

Methods

{{project.node.row[0].project_title != NULL ? project.node.row.length : 0}} Datasets

{{method.number}} Datasets

Data

Access the {{data.data_link.title}}

CTD² Data Portal

{{row.dpp.title}}

Data

Experimental Approaches

Principal Investigator

Contact Name

Reference

{{row.dpp_title}}

Data

Experimental Approaches

Principal Investigator

Contact Name

Reference

Breadcrumb

CTD² Data Portal

{{row.dpp.title}}

Data

Experimental Approaches

Principal Investigator

Contact Name

Reference

{{row.dpp_title}}

Data

Experimental Approaches

Principal Investigator

Contact Name

Reference